van Aspert-van Erp Anniek J M, Smedts Frank M M, Vooijs G Peter
Laboratory of Cytopathology, University Medical Center, Nijmegen, the Netherlands.
Cancer. 2004 Aug 25;102(4):210-7. doi: 10.1002/cncr.20473.
The purpose of the current study was to determine the accuracy of routinely screened cervical smears to predict a glandular cell lesion in histologically confirmed cases of cervical adenocarcinoma in situ (AIS), invasive adenocarcinoma (ADCA), adenosquamous carcinoma (ADSQCA), and severe combined glandular and squamous cell lesions.
Between 1989-2000, a total of 1,141 women with a histologic diagnosis of cervical AIS, ADCA, ADSQCA, and combined lesions (glandular cell lesion with a coexistent squamous cell lesion) were registered in the Dutch National Pathology Archive (PALGA). In 1054 of these 1,141 histologic cases, an additional conventional Papanicolaou (Pap) smear diagnosis was registered from the same patient. Material was evaluated with regard to the accuracy of cytologic diagnosis, the percentage of combined lesions, the mean age of the patients, and the time interval between AIS and ADCA.
Of 1,141 registered histologic cases, 57.5% were registered as having an "intraepithelial" lesion, whereas 42.5% were registered as having an "invasive" process. A combined process was diagnosed in 63.2% of cases. From the same patients, a cytologic diagnosis of a severe cervical epithelial lesion was registered in PALGA for 91.2% (n = 961) of 1054 cases. A cytologic registration of a severe glandular cell lesion (with or without a squamous cell component) was made in 547 cases (51.9%). Prediction of a severe glandular cell lesion on the Pap smear was found to be more accurate in cases of histologically confirmed pure glandular cell abnormalities than in cases with a histologic diagnosis of a combined lesion. The cytologic prediction was found to be correct in 75.2% of cases of pure AIS and 47.3% of cases of AIS with coexistent high-grade squamous intraepithelial lesion (HGSIL) (cervical intraepithelial lesion [CIN] type 2 [CIN 2] or CIN 3). The mean ages of the patients with AIS and AIS + HGSIL were 37.3 years and 34 years, respectively, whereas the mean age of the patients with ADCA and ADCA + HGSIL was 41.9 years and 38.1 years, respectively. The interval between the average ages of patients with AIS and ADCA and those with AIS + HGSIL and ADCA + HGSIL was 4.6 years and 4.1 years, respectively.
On the basis of a data search of the PALGA registry, it can be concluded that in a relatively large number of cases a severe cervical glandular cell lesion was not diagnosed on the Pap smear. Furthermore, data demonstrated that the prediction of a glandular abnormality is less accurate in cases of combined squamoglandular cell lesions than in pure glandular cell lesions.
本研究的目的是确定在组织学确诊的宫颈原位腺癌(AIS)、浸润性腺癌(ADCA)、腺鳞癌(ADSQCA)以及严重的腺细胞与鳞状细胞联合病变病例中,常规筛查宫颈涂片预测腺细胞病变的准确性。
1989年至2000年间,荷兰国家病理学档案库(PALGA)登记了1141例经组织学诊断为宫颈AIS、ADCA、ADSQCA及联合病变(腺细胞病变合并鳞状细胞病变)的女性病例。在这1141例组织学病例中的1054例中,还登记了同一名患者的另一项传统巴氏涂片诊断结果。对材料进行了评估,内容包括细胞学诊断的准确性、联合病变的百分比、患者的平均年龄以及AIS与ADCA之间的时间间隔。
在1141例登记的组织学病例中,57.5%被登记为患有“上皮内”病变,而42.5%被登记为患有“浸润性”病变。63.2%的病例诊断为联合病变。在PALGA中,从同一名患者中,1054例病例中有91.2%(n = 961)登记为宫颈上皮重度病变的细胞学诊断。547例(51.9%)登记有重度腺细胞病变(有或无鳞状细胞成分)的细胞学记录。发现巴氏涂片对组织学确诊的纯腺细胞异常病例中重度腺细胞病变的预测比对组织学诊断为联合病变的病例更准确。细胞学预测在纯AIS病例中75.2%正确,在合并高级别鳞状上皮内病变(HGSIL,宫颈上皮内瘤变[CIN]2级[CIN 2]或CIN 3)的AIS病例中47.3%正确。AIS患者和AIS + HGSIL患者的平均年龄分别为37.3岁和34岁,而ADCA患者和ADCA + HGSIL患者的平均年龄分别为41.9岁和38.1岁。AIS和ADCA患者与AIS + HGSIL和ADCA + HGSIL患者的平均年龄间隔分别为4.6岁和4.1岁。
基于对PALGA登记处的数据检索,可以得出结论,在相当多的病例中,巴氏涂片未诊断出重度宫颈腺细胞病变。此外,数据表明,在鳞状腺细胞联合病变病例中,腺细胞异常的预测不如纯腺细胞病变准确。